by Juliette Boynton | Jul 1, 2019 | Briefings, UK
The case relates to expandable garden hoses, which are now commonly available. Emson is the exclusive sub-licence of two UK patents, which Emson claimed Hozelock have infringed. Hozelock counter claimed for invalidity of both patents. Important features of this hose...
by Alex Bajjon | May 1, 2019 | Briefings, UK
Background The patent in question (EP 1173181) related to a new dosage regime for tadalafil (marketed under the brand name Cialis®) for treating erectile dysfunction (ED). The patent is owned by ICOS and exclusively licensed to Eli Lilly. The claims of the patent...
by Sean Hughes | Mar 1, 2019 | Briefings, UK
Background The Patent in question related to a method of producing platelet rich plasma (PRP) from whole blood. The inventive concept was said to reside in a resuspension step that allowed preparation of PRP from whole blood using only one centrifugation step. The...
by Carolyn Haywood | Mar 1, 2019 | Briefings, Designs & Copyright, Trademarks, UK
The updated guidance note on Brexit and IP provided by the UKIPO makes it clear that the aim of the Government is still for Brexit to cause as little disruption as possible with respect to IP rights. However, despite a ‘no-deal’ Brexit being voted down earlier this...
by Carolyn Haywood | Mar 1, 2019 | Briefings, UK
Background Genentech is the proprietor of European patent (UK) No. 1 641 822 entitled “Il-17A/F heterologous peptides and therapeutic uses thereof”. Genentech does not at present have a product covered by the patent but Lilly market an antibody under the...
Recent Comments